Big Health

Big Health provides digital therapeutics for mental health conditions including insomnia, anxiety, and adolescent depression. Its products—such as Sleepio for insomnia and Daylight for anxiety—are based on cognitive behavioral therapy delivered digitally. The company’s solutions are supported by over a dozen randomized controlled trials with more than ten million covered lives worldwide. Clinical results show significant improvements in sleep quality, reductions in symptoms of anxiety/depression, and enhanced emotional well-being without the side effects associated with medications. The recent acquisition of Limbix expands its reach into adolescent mental health with SparkRx targeting teen depression.